Answers are grounded in this paper and cite their sources.
Rapid technological innovation and artificial intelligence (AI) have transformed not only the resolution at which the brain can be observed, but also the questions that can be asked, shifting the field from description toward prediction, regulation and generation. Yet progress has largely advanced along parallel trajectories, and findings at one level rarely inform or constrain the next. Here, we review recent advances in three exemplary domains and propose a future-oriented framework for their integration. First, molecular and cellular neurotechnology, including synaptic proteomics, cryo-electron tomography, super-resolution microscopy, optoacoustic and ultrasound imaging, sonogenetics and molecular MRI, resolves neural processes with unprecedented specificity. Second, AI-based decoding of human brain activity yields precise signatures of complex, subjective conscious experiences in naturalistic contexts and is beginning to inform diagnosis, drug evaluation and individualized neuromodulation in mental disorders. Third, large-scale neural recordings, mechanistic whole-brain simulations, neural foundation models and AI surrogate brains are converging toward individualized digital twin brains. We argue that the next level of progress requires integrating these domains into a closed loop of reciprocal constraints, in which molecular measurements inform model parameters, human signatures define and evaluate what models must reproduce, and model predictions prioritize perturbations that can be tested across domains.
No takes yet. Share an insight, caveat, or question.
Becker et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: